Cartesian Therapeutics
RNAC
RNAC
44 hedge funds and large institutions have $37.3M invested in Cartesian Therapeutics in 2019 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 6 increasing their positions, 19 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
44% less call options, than puts
Call options by funds: $5K | Put options by funds: $9K
53% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 19
68% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 19
Holders
44
Holding in Top 10
1
Calls
$5K
Puts
$9K
Top Buyers
| 1 | +$858K | |
| 2 | +$730K | |
| 3 | +$419K | |
| 4 |
PP
Paloma Partners
Greenwich,
Connecticut
|
+$275K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$197K |
Top Sellers
| 1 | -$1.83M | |
| 2 | -$667K | |
| 3 | -$606K | |
| 4 |
State Street
Boston,
Massachusetts
|
-$535K |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
-$504K |